4 completed, 2 terminated, 1 not yet recruiting. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Terminated 2, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Terminated 1 |
Follow Taeniasis: new trials by email Literature Review of Taeniasis trials Research Report on Taeniasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oxfendazole in Mild Parenchymal Brain Cysticercosis Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis | Phase 2 / Phase 3 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 544 | 2026-12-01 | 2026-05-01 |
| Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) Albendazole and praziquantel, Albendazole and praziquantel placebo - Neurocysticercosis | Phase 3 | Terminated | Universidad Peruana Cayetano Heredia | 107 | 2016-11-14 | 2022-11-16 |
| Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) Acetazolamide, Dexamethasone - Neurocysticercosis | Phase 2 / Phase 3 | Terminated | Universidad Peruana Cayetano Heredia | 4 | 2015-12-04 | 2025-04-01 |
| Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT 7 days of albendazole 15 mg/kg/day, 28 days of albendazole 15 mg/kg/day - Neurocysticercosis | Phase 3 | Completed | All India Institute of Medical Sciences | 97 | 2014-03-01 | 2016-01-01 |
| Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) Praziquantel, Albendazole, ABZ Placebo - Neurocysticercosis, Epilepsy | Phase 2 / Phase 3 | Completed | Universidad Peruana Cayetano Heredia | 156 | 2010-01-01 | 2015-06-11 |
| Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients Albendazole, Dexamethasone, Omeprazole - Neurocysticercosis | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 110 | 2006-04-01 | 2017-02-03 |
| A Pilot Study of Neurocysticercosis Treatment albendazole, placebo - Neurocysticercosis | Phase 3 | Completed | Columbia University | 178 | 2001-02-01 | 2010-02-08 |
Neurocysticercosis (7) · Cestode Infections (1) · Cysticercosis (1) · Epilepsy (1) · Seizures (1)
Central Nervous System Diseases (7) · Central Nervous System Helminthiasis (7) · Central Nervous System Infections (7) · Central Nervous System Parasitic Infections (7) · Helminthiasis (7) · Infections (7) · Nervous System Diseases (7) · Parasitic Diseases (7) · Cestode Infections (6) · Cysticercosis (6) · Brain Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Albendazole (6) · Dexamethasone (2) · Praziquantel (2) · Acetazolamide (1) · Omeprazole (1) · oxfendazole (1)
Universidad Peruana Cayetano Heredia (4) · All India Institute of Medical Sciences (1) · Columbia University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Peru (4) · Ecuador (1) · India (1)
Hector H. Garcia, MD, PhD (2) · E. Javier Pretell, MD (1) · Hector H Garcia, MD, PhD (1) · Hector H. Garcia Lescano, Ph.D (1) · Hector H. Garcia, MD (1) · Javier A. Bustos, MD (1) · Sheffali Gulati, MD (1) · Theodore E. Nash, MD (1) · W. Allen Hauser, MD (1)
PMID 18495737, PMID 21332573, PMID 24999157, PMID 26984901
R01NS054805 (1)